Philip Kantoff
Director/Board Member bij CONTEXT THERAPEUTICS INC.
Vermogen: 4 873 $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Martin Lehr | M | 40 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 9 jaar |
Linda West | F | 64 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 jaar |
Richard Berman | M | 81 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 jaar |
Jennifer Stacey | F | 59 |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 3 jaar |
Jonathan W. Simons | M | - |
Prostate Cancer Foundation
| 17 jaar |
David Parkinson | M | 73 | 9 jaar | |
Felix Kim | M | - |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | 9 jaar |
Stein Erik Hagen | M | 67 |
Prostate Cancer Foundation
| - |
Evan G. Dick | M | 72 | - | |
Ann Thorell | F | 56 | 5 jaar | |
Michael Robert Milken | M | 78 |
Prostate Cancer Foundation
| 31 jaar |
Scott Requadt | M | 56 | 8 jaar | |
Gary Sollis | M | 69 | 12 jaar | |
Alex Martin Martin | M | 55 | 5 jaar | |
Richard Glickman | M | 65 | 14 jaar | |
Jennifer Minai-Azary | F | 47 | 3 jaar | |
Sanford Zweifach | M | 68 | 5 jaar | |
Franklin Berger | M | 74 | 9 jaar | |
Neil Bander | M | - |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | - |
Alex Levit | M | 45 | 3 jaar | |
Charles J. Ryan | M | - |
Prostate Cancer Foundation
| 3 jaar |
Robert Sachs | M | 76 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 26 jaar |
Robin Richards | M | 67 |
Prostate Cancer Foundation
| - |
Lauren Merendino | F | 49 | 1 jaar | |
Molly Globus | F | - |
Prostate Cancer Foundation
| - |
Roosevelt Grier | M | - |
Prostate Cancer Foundation
| - |
Peter Virsik | M | - | 8 jaar | |
Jared Carney | M | - |
Prostate Cancer Foundation
| - |
Christopher Beck | M | - | 2 jaar | |
Alexander Brown | M | - |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | 3 jaar |
Eric Sullivan | M | - |
Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Convergent Therapeutics, Inc. is a clinical stage pharmaceutical company located in Cambridge, MA. The company focuses on developing next generation radiopharmaceutical therapies for prostate and other cancers. The company's proprietary technology involves dual-targeted radionuclide therapy (RNT) developed by Dr. Neil Bander, a professor of urologic oncology at Weill Cornell Medicine and licensed to Convergent by Cornell University. The company's lead product candidate, Conv01-?, is a monoclonal antibody conjugated with actinium-225 (225Ac), a radioactive alpha particle emitter, designed to bind to the prostate-specific membrane antigen (PSMA). If FDA-approved, Conv01-? would be the first antibody approved to direct a radioisotope to prostate cancer, and the first drug approved for the use of 225Ac in a cancer treatment. The company was founded by Philip Wayne Kantoff and Neil H. Bander, and Philip Wayne Kantoff has been the CEO since incorporation. | 1 jaar |
Christine Jones | F | - |
Prostate Cancer Foundation
| 6 jaar |
Daniel J. DeAngelo | M | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 25 jaar |
Cigall Kadoch | M | 39 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 10 jaar |
Wai Keong See Toh | F | - |
Prostate Cancer Foundation
| 24 jaar |
Nelson Peltz | M | 81 |
Prostate Cancer Foundation
| - |
Stuart Holden | M | 82 |
Prostate Cancer Foundation
| 31 jaar |
Alessandra Cesano | M | 63 | 5 jaar | |
David A. Ederer | M | 81 |
Prostate Cancer Foundation
| - |
Peter Grauer | M | 79 |
Prostate Cancer Foundation
| - |
Neil DeFeo | M | 78 |
Prostate Cancer Foundation
| - |
Robert Perez | M | 59 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 11 jaar |
Steven A. Burd | M | 74 |
Prostate Cancer Foundation
| - |
James Blair | M | 84 |
Prostate Cancer Foundation
| - |
H. Norman Schwarzkopf | M | 89 |
Prostate Cancer Foundation
| - |
Bert C. Roberts | M | 81 |
Prostate Cancer Foundation
| - |
Richard LeFrak | M | 78 |
Prostate Cancer Foundation
| - |
R. Christian Evensen | M | 67 |
Prostate Cancer Foundation
| - |
Andrew Miller | M | - |
Prostate Cancer Foundation
| - |
Andrew Janower | M | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 9 jaar |
Emilio Bassini | M | 74 |
Prostate Cancer Foundation
| - |
David Wood | M | 66 | 11 jaar | |
Richard S. Boskey | M | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 25 jaar |
Anne L. Levine | F | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 29 jaar |
Susan S. Paresky | F | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 27 jaar |
Lynda Resnick | F | 80 |
Prostate Cancer Foundation
| - |
Thomas Smith | M | 58 |
Prostate Cancer Foundation
| - |
Daniel Santaniello | M | 58 |
Prostate Cancer Foundation
| - |
Priya Marreddy | F | - | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Edward Benz | M | 78 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 16 jaar |
Dorothy Puhy | F | 72 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 25 jaar |
Ronald DePinho | M | 69 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | - |
Steven J. Burakoff | M | 81 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 15 jaar |
Robert P. Allen | M | - |
Brown University
| 4 jaar |
Karen Bird | F | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | - |
Robert J. Molinari | M | - |
Brown University
| 3 jaar |
Jay B. Horowitz | M | - |
Brown University
| 4 jaar |
Jamie H. Kase | M | - |
Brown University
| 4 jaar |
Patrick Shattenkirk | M | - |
Brown University
| 4 jaar |
Steven Pickhardt | M | - |
Brown University
| 4 jaar |
Warren Kanders | M | 66 |
Brown University
| 4 jaar |
Peter W. Wallis | M | - |
Brown University
| 4 jaar |
Peter Kevin Poli | M | 63 |
Brown University
| 4 jaar |
Thomas C. Downs | M | - |
Brown University
| 4 jaar |
Grove Newhard Mower | M | - |
Brown University
| 4 jaar |
Ron Florance | M | - |
Brown University
| 4 jaar |
Jeff Canin | M | - |
Brown University
| 4 jaar |
Amy George | F | 62 |
Brown University
| 4 jaar |
James C. Baird | M | - |
Brown University
| 4 jaar |
Jennifer Moses | F | - |
Brown University
| 4 jaar |
Robert Adrian | M | - |
Brown University
| 4 jaar |
Paul R. S. Gebhard | M | - |
Brown University
| 4 jaar |
Rich Alan Friedman | M | 65 |
Brown University
| 4 jaar |
Alan J. Bernon | M | - |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | 12 jaar |
Michael Micallef | M | 74 |
Brown University
| 4 jaar |
Kuo Yen Kau | M | 62 |
Brown University
| 4 jaar |
Charles Giancarlo | M | 66 |
Brown University
| 4 jaar |
Raymond A. Roel | M | 68 |
Brown University
| 4 jaar |
John J. Gorman | M | 68 |
Brown University
| 4 jaar |
Marcia J. Hooper | F | 69 |
Brown University
| 2 jaar |
Barry Sholem | M | 68 |
Brown University
| 4 jaar |
David Corrsin | M | 65 |
Brown University
| 4 jaar |
Thomas Frame | M | - |
Brown University
| 4 jaar |
Henrik Jones | M | - |
Brown University
| 4 jaar |
Timothy S. Hearn | M | - |
Brown University
| 4 jaar |
John Ettelson | M | - |
Brown University
| 4 jaar |
Peter Thompson | M | 64 |
Brown University
| 4 jaar |
Barkley J. Stuart | M | - |
Brown University
| 4 jaar |
Peter Segall | M | 62 |
Brown University
| 4 jaar |
Christopher Graham | M | - |
Brown University
| 5 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 88 | 88.00% |
Canada | 12 | 12.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Philip Kantoff
- Persoonlijk netwerk